Reversible Dibromomaleimide Peptide Stapling: Fine-Tuning Helical Peptide Drug Design | Research

The takeaway

Structural optimization of reversible dibromomaleimide stapling using native cysteine/homocysteine residues at i, i+4 positions enables tunable α-helical stabilization of peptides targeting protein-protein interactions.

Reversible stapling
Unlike permanent hydrocarbon staples, dibromomaleimide stapling can be reversed — enabling peptides that stabilize for delivery but unstaple at the target

What the researchers found

Optimized reversible dibromomaleimide stapling of peptides using native Cys/homoCys at i, i+4 positions. Structural analysis revealed conformation-activity relationships for α-helical peptide stabilization targeting protein-protein interactions.

Why it matters

Reversible stapling adds a design dimension: peptides can be stabilized for delivery but potentially unstapled at the target site. This "smart stapling" concept could improve peptide drug efficacy and reduce off-target effects.

The numbers in context

i, i+4 spacing; Ac-X1AAAX5-NH2 model; optimal X1=L-Cys, X5=L-hCys

How the study worked

Medicinal chemistry study. Dibromomaleimide stapling of peptides with native cysteine residues. Structural characterization (NMR, CD). Binding affinity assessment. Reversibility demonstration.

Who was studied

N/A (model peptide chemistry)

What this study cannot tell us

Structural optimization study — therapeutic efficacy not tested. Reversibility conditions may not match biological requirements. Limited peptide sequences tested.

How to read the evidence

Low evidence grade: structural optimization study without biological activity testing.

When this study was published

Published 2021. Reversible peptide modification chemistry continues advancing.

The bigger picture

Reversible covalent chemistry is a growing trend in drug design. Applying it to peptide stapling creates "smart" peptide drugs that can switch between stabilized and unstabilized conformations in response to biological conditions.

Questions still open

Under what biological conditions does the staple reverse?
Would reversible stapling improve or reduce in vivo peptide drug efficacy?
Can this approach be applied to other stapling positions (i, i+7)?

Common questions

What is peptide stapling?

Peptide stapling is a chemical modification that locks a peptide into its active shape (usually a helix) using a molecular "bridge" or "staple." This makes the peptide more stable, better at binding its target, and more resistant to degradation.

Why would reversible stapling be useful?

Reversible stapling could create peptides that are stabilized during delivery (surviving in the bloodstream) but unstaple at the disease site, potentially exposing additional binding surfaces or enabling the peptide to adopt its natural flexible state for optimal target interaction.

Read the original research

Structural optimization of reversible dibromomaleimide peptide stapling.

Peptide science (Hoboken, N.J.), 113(1), e24157

View on PubMed ↗Publisher’s paper ↗

Citation

Lindsey-Crosthwait, Ayanna; Rodriguez-Lema, Diana; Walko, Martin; Pask, Christopher M; Wilson, Andrew J. (2021). Structural optimization of reversible dibromomaleimide peptide stapling.. Peptide science (Hoboken, N.J.), 113(1), e24157. https://doi.org/10.1002/pep2.24157